Article
Receptor for advanced glycation end-product rs1800624 polymorphism contributes to increase breast cancer risk: Evidence from a meta-analysis.
Medicine - 30 Oct 2020
Zhang Wei, Deng Xiaowei, Tang Ruijun, Wang Hong
Abstract excerpt
BACKGROUND: Although several studies have identified an association between the receptor for advanced glycation end-product (RAGE) rs1800624 polymorphism and breast cancer, the results have been conflicting. Therefore, we conducted a meta-analysis to assess the relationship between the RAGE rs1800624 polymorphism and breast cancer risk. METHODS: Studies were searched in the PubMed, Web of Science, Embase, Wanfang...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
